News

News Remiges selected as Certified VC by the AMED Drug Discovery Venture Ecosystem Enhancement Program

Remiges selected as Certified VC by the AEMD Drug Discovery Venture Ecosystem Enhancement Program

06/30/2022

The Japan Agency for Medical Research and Development (AMED) in Japan announced today that Remiges was selected as one of the Certified VCs in Drug Discovery Ecosystem Enhancement Program.

The program provides certain services including financial supports for drug discovery startup companies in which Certified VCs invest.

For more detailed information please visit the above AMED web pages.